Dr. Christopher G. Gibson, DO
Rheumatology (Rheumatology Physician)
Who else practices at this address →
Fremont County is a federal primary care shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Ohio University, College of Osteopathic Medicine (2018)
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 101
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Medical school: Ohio University, College of Osteopathic Medicine
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
ID license O-1790 -
Internal Medicine Physician
LA license 327342 · OH license 58.029999
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mountain View Hospital Idaho Falls, ID
- Portneuf Medical Center Pocatello, ID
- Bingham Memorial Hospital Blackfoot, ID
- Minidoka Memorial Hospital Rupert, ID
- Lost Rivers Medical Center Arco, ID
Medical groups
- Minidoka Memorial Hospital (39 clinicians)
- Rocky Mountain Medical LLC (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 101
- Services billed
- 432
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 34 | 25 |
| New patient office or other outpatient visit, 60-74 minutes | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydroxychloroquine Sulfate Other prescribers in Ashton, ID | 256 |
| Methotrexate (methotrexate sodium) Other prescribers in Ashton, ID | 122 |
| Prednisone Other prescribers in Ashton, ID | 117 |
| Leflunomide Other prescribers in Ashton, ID | 56 |
| Enbrel Sureclick (etanercept) Other prescribers in Ashton, ID | 56 |
| Colchicine Other prescribers in Ashton, ID | 43 |
| Omeprazole Other prescribers in Ashton, ID | 34 |
| Mycophenolate Mofetil Other prescribers in Ashton, ID | 27 |
| Celecoxib Other prescribers in Ashton, ID | 26 |
| Methylprednisolone Other prescribers in Ashton, ID | 20 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 83 payments worth $11,918 in total to this clinician.
| UCB, Inc. | $10,490 |
|---|---|
| Amgen Inc. | $667 |
| Alexion Pharmaceuticals, Inc. | $250 |
| Janssen Biotech, Inc. | $212 |
| Lilly USA, LLC | $110 |
| Novartis Pharmaceuticals Corporation | $92.04 |
| Ani Pharmaceuticals, Inc. | $48.29 |
| AbbVie Inc. | $29.20 |
| Consulting Fee | $8,550 |
|---|---|
| Food and Beverage | $1,735 |
| Travel and Lodging | $1,498 |
| Education | $135 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Sep 11, 2025 | Consulting Fee Bimzelx · Immunology | $8,550 |
| UCB, Inc. Aug 23, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Atlanta, GA · in-kind | $928 |
| UCB, Inc. Aug 23, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Atlanta, GA · in-kind | $333 |
| UCB, Inc. Aug 23, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Atlanta, GA · in-kind | $200 |
| Janssen Biotech, Inc. Jul 30, 2025 | Education TREMFYA · Immunology · in-kind | $77.99 |
| Janssen Biotech, Inc. Mar 17, 2025 | Education TREMFYA · Immunology · in-kind | $56.99 |
| UCB, Inc. Aug 23, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Atlanta, GA · in-kind | $36.27 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $16,720 in research payments for these studies, mostly to the institutions running them.
- An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Eli Lilly and Company · Completed · NCT05848258 - Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Eli Lilly and Company · Completed · NCT06588296
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.